Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – Here’s What Happened

Oxford BioMedica (OTCMKTS:OXBDF) shares gapped down before the market opened on Friday . The stock had previously closed at $8.00, but opened at $6.88. Oxford BioMedica shares last traded at $6.88, with a volume of 1,000 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Oxford BioMedica Stock Down 6.3%

The company has a 50 day moving average of $7.88 and a 200-day moving average of $8.58.

About Oxford BioMedica

Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.

In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.